Accession | Title | Series type(s) | Organism(s) | Samples | GDS | Supplementary | Contact | Release date |
---|---|---|---|---|---|---|---|---|
Filter | Genome binding/occupancy profiling by high throughput sequencing | Homo sapiens | TXT | |||||
GSE84365 |
RNA-seq and ChIP-seq data of ASXL1/2 in Hematopoiesis
|
|
|
54 | Omar Abdel-Wahab | Jun 26, 2017 | ||
GSE119103 |
Corrupted coordination of epigenetic modifications leads to diverging chromatin states and transcriptional heterogeneity in chronic lymphocytic leukemia
|
|
90 |
|
Omar Abdel-Wahab | May 02, 2019 | ||
GSE199539 |
A genome-wide CRISPR activation screen identifies PRRX2 as a regulator of enzalutamide resistance in prostate cancer
|
|
16 |
|
Sarki Abdulkadir | Mar 30, 2022 | ||
GSE60200 |
Quantitative modeling of transcription factor binding specificities using DNA shape
|
|
1 |
|
Namiko Abe | Mar 01, 2015 | ||
GSE161236 |
The histone acetyltransferase HBO1 (KAT7) promotes efficient tip cell sprouting during angiogenesis
|
|
7 |
|
Waruni Abeysekera | Sep 30, 2021 | ||
GSE161893 |
The histone acetyltransferase HBO1 (KAT7) promotes efficient tip cell sprouting during normal and pathogenic angiogenesis
|
|
|
14 | Waruni Abeysekera | Sep 30, 2021 | ||
GSE39229 |
Mapping Epigenomic Type-Specific Differences Occurring During Hematopoiesis
|
|
14 | Brian J Abraham | Mar 25, 2013 | |||
GSE39538 |
Mapping Epigenomic Type-Specific Differences Occurring During Hematopoiesis [ChIP-Seq]
|
|
13 |
|
Brian J Abraham | Mar 25, 2013 | ||
GSE159617 |
EP300 selectively controls the enhancer landscape of MYCN-amplified neuroblastoma
|
|
39 |
|
Brian J Abraham | Nov 09, 2021 | ||
GSE212077 |
STAT3 couples activated tyrosine kinase signaling to the oncogenic core transcriptional regulatory circuitry of anaplastic large cell lymphoma
|
|
47 |
|
Brian J Abraham | Aug 26, 2022 | ||
GSE118716 |
Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine resistant breast cancer
|
|
40 | Joanna Achinger-Kawecka | Dec 11, 2019 | |||
GSE171074 |
The potential of epigenetic therapy to target the 3D epigenome in endocrine-resistant breast cancer
|
|
88 |
|
Joanna Achinger-Kawecka | Dec 12, 2021 | ||
GSE45023 |
Genome-wide maps of chromatin state for H3.3 tagged cells
|
|
3 | Peter D. Adams | Apr 18, 2013 | |||
GSE45024 |
Genome-wide maps of chromatin state for HIRA, UBN1 and ASF1a
|
|
4 | Peter D. Adams | Apr 18, 2013 | |||
GSE45025 |
Placing the HIRA histone chaperone complex in the chromatin landscape
|
|
15 | Peter D. Adams | Apr 18, 2013 | |||
GSE74863 |
Expression data and HIRA ChIP-seq data from interferon treated IMR90 cells
|
|
22 | Peter Adams | Jan 09, 2018 | |||
GSE193704 |
Oncogenic YAP mediates changes in chromatin accessibility and activity that drive cell cycle gene expression and cell migration
|
|
30 |
|
Carsten P Ade | Feb 15, 2023 | ||
GSE198518 |
Splicing modulators impair DNA damage response and induce killing of cohesin-mutant MDS/AML
|
|
46 | Karen Adelman | Jun 30, 2023 | |||
GSE164849 |
Spatially mapped single-cell chromatin accessibility
|
|
|
5 |
|
Andrew Adey | Jan 15, 2021 | |
GSE55887 |
Genome-wide analysis reveals characteristics of off-target sites bound by the Cas9 endonuclease
|
|
12 | Mazhar Adli | May 18, 2014 |